Dietary fish oil sensitizes A549 lung xenografts to doxorubicin chemotherapy

Cancer Letters

Volumn 151, Issue 2, 2000, Pages 145-151

  Hardman, W Elaine ^a   Moyer, Mary Pat ^b,c   Cameron, Ivan L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NONE   (United States)

Author keywords

A549 lung cancers; Doxorubicin; Fish oil; Polyunsaturated fatty acids

Indexed keywords

CORN OIL; DOXORUBICIN; FERRIC CITRATE; FISH OIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; HUMAN; HUMAN CELL; LUNG TUMOR; MALE; MOUSE; PRIORITY JOURNAL; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CELL DIVISION; CORN OIL; DIETARY FATS, UNSATURATED; DOXORUBICIN; DRUG SYNERGISM; FERRIC COMPOUNDS; FISH OILS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; REMISSION INDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MUS MUSCULUS; ZEA MAYS;

EID: 0034647036     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00396-1     Document Type: Article

References (28)

1. Atkinson T.G., Meckling-Gill K.A. Regulation of nucleoside drug toxicity by transport inhibitors and omega-3 polyunsaturated fatty acids in normal and transformed rat-2 fibroblasts. Cell. Pharmacol. 2:1995;259-264.
2. Atkinson T.G., Murray L., Berry D.M., Ruthig D.J., Meckling-Gill K.A. DHA feeding provides host protection and prevents fibrosarcome-induced hyperlipidemia while maintaining the tumor response to AraC in Fischer 344 rats. Nutr. Cancer. 28:1997;225-235.
3. Barber M.D., Ross J.A., Voss A.C., Tisdale M.J., Fearon K.C.H. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br. J. Cancer. 81:1999;80-86.
4. Beck S.A., Smith K.L., Tisdale M.J. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 51:1991;6089-6093.
5. Begin M.E., Ells G., Das U.N., Horrobin D.F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J. Natl. Cancer Inst. 77:1986;1053-1062.
6. Begin M.E., Ells G., Horrobin D.F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst. 80:1988;188-194.
7. Borgeson C.E., Pardini L., Pardini R.S., Reitz R.C. Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes. Lipids. 24:1989;290-295.
8. Bougnoux P., Chajes V., Hubert B., Germain E., Lhuillery C., Saez S., Calais G. N-3 polyunsaturated fatty acids and chemosensitivity of breast carcinoma. Proc. Am. Assn. Cancer Res. 36:1995;327.
9. Burns C.P., Spector A.A. Membrane fatty acid modifications in tumor cells: potential therapeutic adjunct. Lipids. 22:1987;178-184.
10. Das U.N., Madhavi G., Kumar G.S., Padma M., Sangeetha P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukotrienes Essent. Fatty Acids. 58:1998;39-54.
11. de Salis H.M., Meckling-Gill K.A. EPA and DHA alter nucleoside drug and doxorubicin toxicity in L1210 cells but not in normal murine S1 macrophages. Cell. Pharmacol. 2:1995;69-74.
12. de Vries C.E.E., Van Noorden C.J.F. Effects of dietary fatty acid composition on tumor growth and metastasis. Anticancer Res. 12:1992;1513-1522.
13. R.T. Dorr, D.D. Von Hoff, Cancer Chemotherapy Handbook, Appleton & Lange, CT, (1994).
14. Hardman W.E., Barnes C.J., Knight C.W., Cameron I.L. Effects of iron supplementation and ET-18-OCH3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet. Br. J. Cancer. 76:1997;347-354.
15. Hardman W.E., Moyer M., Cameron I.L. Fish oil supplementation enhanced CPT-11 (Irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side effects. Br. J. Cancer. 81:1999;440-448.
16. Hornstra G., van Houwelingen A.C., Kivits G.A.A., Fischer S., Uedelhoven W. Dietary fish and prostanoid formation in man. Adv. Prostaglandin Thromboxane Leukotrienes. Res. 21:1990;225-228.
17. Hwang D. Essential fatty acids and immune response. FASEB J. 3:1989;2052-2055.
18. Lands W.E.M., Morris A., Libelt B. Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids. 25:1990;505-516.
19. Maehle L., Eilertsen E., Mollerup S., Schonberg S., Krokan H.E., Haugen A. Effects of n-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of two human tumour cell lines. Br. J. Cancer. 71:1995;691-696.
20. McCarty M.F. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med. Hypotheses. 46:1996;107-115.
21. Moyer M.P., Aust J.B. Human colon cells: culture and in vitro transformation. Science. 224:1984;1445-1447.
22. Price S.A., Tisdale M.J. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res. 58:1998;4827-4831.
23. Reddy B.S., Sugie S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48:1988;6642-6647.
24. Rose D.P., Rayburn J., Hatala M.A., Connolly J.M. Effects of dietary fish oil on fatty acids and eicosanoids in metastasizing human breast cancer cells. Nutr. Cancer. 22:1994;131-141.
25. Shao Y., Hull J., Pardini L., Pardini R.S. Dietary menhaden oil improves the therapeudic index of cyclophosphamide and 5-fluorouracil towards MX-1 human mammary carcinoma in athymic mice. Proc. Am. Assn. Cancer Res. 38:1997;110.
26. Shao Y., Pardini L., Pardini R.S. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids. 30:1995;1035-1045.
27. Tisdale M.J. Mechanism of lipid mobilization associated with cancer cachexia: interaction between polyunsaturated fatty acid, eicosapentaenoic acid and inhibitory guanine nucleotide-regulatory protein. Prostaglandins Leukotrienes Essent. Fatty Acids. 48:1993;105-109.
28. Weber P.C., Sellmayer A. Modification of the prostanoid system and cell signalling by precursor fatty acids. Adv. Prostaglandin Thromboxane Leukotrienes. Res. 21:1990;217-224.